Back to CVE records
High 7.1Published Feb 19, 2026

CVE-2026-26317OpenClaw is a personal AI assistant.

Updated under an hour ago ()

Does this affect you?

It affects openclaw. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

OpenClaw is a personal AI assistant. Prior to 2026.2.14, browser-facing localhost mutation routes accepted cross-origin browser requests without explicit Origin/Referer validation. Loopback binding reduces remote exposure but does not prevent browser-initiated requests from malicious origins. A malicious website can trigger unauthorized state changes against a victim's local OpenClaw browser control plane (for example opening tabs, starting/stopping the browser, mutating storage/cookies) if the browser control service is reachable on loopback in the victim's browser context. Starting in version 2026.2.14, mutating HTTP methods (POST/PUT/PATCH/DELETE) are rejected when the request indicates a non-loopback Origin/Referer (or `Sec-Fetch-Site: cross-site`). Other mitigations include enabling browser control auth (token/password) and avoid running with auth disabled.

CVSS
7.1 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:L
Weakness (CWE)
CWE-352
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Jun 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
openclaw openclaw
openclaw:openclaw
before 2026.2.14
NVD

References

  • patch
  • release-notes
  • patch, vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.